Phase 2 study of an HIV-1 canarypox vaccine (vCP1452) alone and in combination with rgp120: Negative results fail to trigger a phase 3 correlates trial

Nina D. Russell, Barney S. Graham, Michael C. Keefer, M. Juliana McElrath, Steve G. Self, Kent J. Weinhold, David C. Montefiori, Guido Ferrari, Helen Horton, Georgia D. Tomaras, Sanjay Gurunathan, Lynn Baglyos, Sharon E. Frey, Mark J. Mulligan, Clayton D. Harro, Susan P. Buchbinder, Lindsey R. Baden, William A. Blattner, Beryl A. Koblin, Lawrence Corey

Research output: Contribution to journal › Article › peer-review

87 Scopus citations

Fingerprint

Dive into the research topics of 'Phase 2 study of an HIV-1 canarypox vaccine (vCP1452) alone and in combination with rgp120: Negative results fail to trigger a phase 3 correlates trial'. Together they form a unique fingerprint.

Medicine & Life Sciences